Enoxapride 40mg Injection
Item requires a valid prescription
Manufactured By PUNISKA HEALTHCARE PVT LTD
Composition ENOXAPARIN
Rs 196.00
MRP Rs 456.47
(57% OFF)
Includes all taxes
Package SIZE
( 1 PREFILLED SYRINGE(s) OF 0.4ML )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description: Enoxapride 40mg Injection is an anticoagulant drug belonging to the category of low molecular weight heparin (LMWH). It contains the active ingredient Enoxaparin. It is used to treat severe blood clots. This drug also prevents the occurrence of deep vein thrombosis in abdominal surgery, hip replacement surgery, knee replacement surgery, and in people with severe movement restrictions. This injection prevents further heart complications in patients with unstable angina and non-Q wave myocardial infarction.
Enoxapride 40mg Injection is not recommended for patients with active bleeding, hypersensitivity, or allergies to the active compound, as well as those with a history of heparin-induced thrombocytopenia, before taking Enoxapride 40mg Injection, tell your physician if you are allergic to Enoxaparin, heparin, benzyl alcohol, or pork products.
Your healthcare provider will regularly monitor you for signs of bleeding. Inform your healthcare practitioner if you are diagnosed with kidney problems. It is not recommended for use in children and adolescents below 18 years.
Enoxapride 40mg Injection is not recommended if you undergo procedures like neuraxial anaesthesia or spinal puncture. It is recommended to monitor older adults and patients with low weight for increased risk of bleeding.
Tell your physician if you suspect pregnancy, breastfeeding, or planning to have a baby. Enoxapride 40mg Injection may increase the chance of bleeding in pregnant women with artificial heart valves, and hence, close monitoring must be done.
Consult your doctor for more advice before starting Enoxapride 40mg Injection medication, it is recommended not to take any hemostatic drugs unless absolutely necessary. It is needed to inform your physician about all the drugs you are taking, including herbal and vitamin supplements.
Uses / Indications: Enoxapride 40mg Injection is used in the treatment of the following: • Deep vein thrombosis • Prophylaxis of venous thrombo-embolism • Unstable angina • ST-segment Elevation Myocardial Infarction (STEMI) • Prevention of blood clots during surgeries
- Product composition:
- ENOXAPARIN
Interactions / Warnings: • Store Enoxapride 40mg Injection below 25 °C.
• Do not freeze
• Keep it out of reach from children.
• Protect them from light and moisture.
- Pregnancy interaction:
- Pregnancy (Consult your doctor): Before beginning therapy with Enoxapride 40mg Injection, tell your doctor if you are pregnant, suspect you are pregnant, or are planning to become pregnant. It is not known that Enoxapride 40mg Injection interferes with pregnancy.
- Expert advice:
- Enoxapride 40mg Injection can cause bleeding and many undesirable side effects; hence it is advised to get adequate rest during the treatment. Eat a well-balanced diet. Apply a cool compress at the injection site to reduce pain and irritation. Enoxapride 40mg Injection should not be stopped suddenly without first talking to your doctor because doing so may raise your risk of blood clots. Aspirin and other non-steroidal anti-inflammatory medicines (NSAIDs) may increase the risk of bleeding when combined with Enoxapride 40mg Injection, so it is not recommended to take them without first talking to your doctor. Keep away from activities that put you at higher risk of bleeding or getting hurt, like contact sports and activities. Foods high in Vitamin K may have an impact on blood clotting and may interfere with the way anticoagulant drugs like Enoxapride 40mg Injection. It is recommended to eat leafy green vegetables, asparagus, Brussels sprouts and soybean oil in moderation. It is advised to monitor your platelet count regularly.
- Side Effects:
- Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious side effects of Enoxapride 40mg Injection are: • Severe allergic reactions (swelling of lips, tongue, or throat, difficulty breathing, or swallowing) • Too much bleeding (weakness, being pale, dizziness with headache, or unexplained swelling) • Blockage of blood vessels (pain, redness, or swelling in the legs, or coughing up blood) • Rash of dark red spots under the skin Common side effects of Enoxapride 40mg Injection are: • Bleeding • Bruising more easily • Low blood cell counts • Headache • Itchy red skin • Edema • Pain at the injection site • Pink patches on the skin
- How to use:
- Enoxapride 40mg Injection will be administered to you by a healthcare professional in a hospital setting. It is usually administered as an intravenous injection into a vein. Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.
- How it works:
- Enoxapride 40mg Injection binds to the antithrombin to form a complex. Antithrombin is a protein that blocks the formation of abnormal blood clots. This drug mainly prevents the activation of factor Xa, eventually preventing clot formation. It is commonly used for the prevention and treatment of conditions associated with increased risk of blood clots.
- Faq for medicine:
- Q: Who should not take Enoxapride 40mg Injection? A: Enoxapride 40mg Injection is not recommended for people suffering from active major bleeding or a history of hypersensitivity to this drug, heparin, Benzyl alcohol, or pork products. This drug is also not advised for people with a history of heparin-induced thrombocytopenia in the past hundred days. Q: What should I not take with Enoxapride 40mg Injection? 3. 4. 5. 6. A: When taking Enoxapride 40mg Injection, it's important to avoid certain medications, supplements, and activities that may increase the risk of bleeding or interact with the anticoagulant effects of Enoxapride 40mg Injection includes other anticoagulants, non-steroidal anti-inflammatory drugs, and anti-platelets. Q: How should Enoxapride 40mg Injection be stored? A: Enoxapride 40mg Injection should be stored at room temperature (between 68°F to 77°F or 20°C to 25°C) away from light and moisture. It should be kept out of the reach of children and not be frozen. Unused portions of Enoxapride 40mg Injection solution should be discarded according to the manufacturer's instructions. Q: When should you report to the doctor while using Enoxapride 40mg Injection? A: Contact your physician directly if you experience severe allergic reactions like the spelling of lips, tongue, throat, difficulty breathing or swallowing, unexplained swelling, painful Rash, chest pain, or blood in the cough during the treatment with Enoxapride 40mg Injection. Q: How long should Enoxapride 40mg Injection treatment continue? A: The duration of Enoxapride 40mg Injection treatment depends on the underlying condition being treated, the risk of clotting, and individual patient factors. Treatment may be short-term (e.g., during hospitalisation or surgical procedures) or long-term for chronic conditions such as DVT or PE. Q: What are the common side effects of Enoxapride 40mg Injection? A: Common side effects of Enoxapride 40mg Injection may include bleeding or bruising at the injection site, nosebleeds, nausea, headache, and itching. Serious side effects such as severe bleeding or allergic reactions are rare but may occur.
- Medicine interaction:
- Some medicinal products that affect haemostasis should be discontinued before starting Enoxapride 40mg Injection therapy unless absolutely necessary. If a combination is required, Enoxapride 40mg Injection should be used with careful clinical and laboratory monitoring. These products include systemic salicylates, acetylsalicylic acid at anti-inflammatory doses, NSAIDs like ketorolac, other thrombolytics such as alteplase, reteplase, streptokinase, tenecteplase, urokinase, and other anticoagulants. Always inform your doctor about any medicines or supplements you are taking, as they may interact with Enoxapride 40mg Injection.
